RecruitingNCT06311149

Multicenter Evaluation of Patients Using LATITUDE Monitoring System

Multicenter Evaluation of Patients Using LATITUDE Monitoring System: Multitude Study

Sponsor

University Hospital of Ferrara

Enrollment

20,000 participants

Start Date

Dec 1, 2023

Study Type

OBSERVATIONAL

Conditions

Heart Failure Cardiovascular Diseases Arrhythmias, Cardiac Sudden Cardiac Death

Summary

The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database. The registry is designed to constitute a shared environment for the collection, management, analysis and reporting of clinical and diagnostic data, adopted by a network of European scientifically-motivated physicians who use rhythm management diagnostic and therapeutic solutions from Boston Scientific in their clinical practice. The Multitude study will facilitate the sharing of scientific proposals within a large network of researchers, and it will allow researchers to record the experience with medical devices throughout the device and patient lifecycle.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study collects long-term health data from patients who have received an implantable heart device (such as a pacemaker, defibrillator, or cardiac resynchronization device) that is monitored remotely via the LATITUDE monitoring system. The goal is to better understand long-term device performance and patient outcomes in the real world. **You may be eligible if...** - You are receiving or have already received a heart device that uses the LATITUDE remote monitoring system - You are willing to consent to your health data being collected and stored - You expect to remain under follow-up care at the enrolling center for at least 1 year **You may NOT be eligible if...** - You are not expected to be followed at the enrolling center for at least 1 year after receiving the device - Your device has not been approved for commercial use Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.